Dr. Doug is a PhD trained in Biochemistry and Molecular Immunology with over thirty years of research experience in a range of fields including Translational Biology, Statistics and Bioinformatics, signal transduction, immune regulation and oncology. He received a Bachelor’s of Science degree with a double major in Biology and Chemistry from the University of Richmond, as well as a Minor in Mathematics. He received his PhD in Molecular Biology and Biochemistry from Wake Forest University. His graduate work focused upon cellular signaling mediated by circulating materials released by tumors, leading to the discovery of the exosome biology field. He has also received postdoctoral research training at Boston University School of Medicine in the area of Cellular Immunology and Immune Regulation. His most recent area of research interest has been in cancer cell biology and immunoregulation. Dr. Doug has served as a faculty member at a cancer research institute, as well as at graduate-level research universities. He has developed training materials for academic and biotechnology groups, providing guidance and expertise in generating documents associated with clinical trials and overseeing compliance with GMP/ GLP, FDA LDT, IRB regulations and preparation of regulatory documents. Dr. Doug has extensive experience in preparing and writing reports/summaries (technical and layman), business plans, and other investment documents for both academic and industrial applications. He has over 30 years of experience in the successful development and writing of NIH R01, R03, R21, STTR and SBIR grant applications and investigator-initiated Department of Defense applications. In addition to preparing grant applications, Dr. Doug has served as a member of multiple NIH Study Sections and as a Chairman of Department of Defense Study Sections, where he reviewed and evaluated proposed research initiatives, emphasizing new approaches and technologies. Dr. Doug has published over 100 peer-reviewed articles. He has also served as an Associate Editor for Cancer Research and Biomarker Insights and as Editor-in-Chief of Exosomes and Microvesicles and reviewer for multiple journals, including Cancer Research, Clinical Cancer Research and Journal of Immunology. As a published and extramurally-funded scientist, Dr. Doug understands the process of preparing manuscripts, grant applications and other academic documents for submission, and enjoys helping other scientists polish their own materials. He welcomes the opportunity to edit papers, grant proposals, and regulatory documents in Biotechnology, Molecular and Cellular Biology, Bioinformatics, Signal Transduction, Extracellular Vesicles, Genomics, Proteomics, Oncology, and all aspects of Immunology.
To work with immunology editor and grant writer Dr. Doug, please visit our quote page and request him in the description area.